Provention bio to present at the stifel virtual healthcare conference

Red bank, n.j., nov. 11, 2020 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing autoimmune disease, today announced that management will present at the stifel virtual healthcare conference on wednesday, november 18,...

PRVB Ratings Summary

PRVB Quant Ranking